Johnstone Tcheou

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial”.

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101323

N/A

1.3DataRank · unranked

55 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +42 more

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

Cell Reports(2024)10.1016/j.celrep.2024.114922

N/A

0.805DataRank · unranked

37 citations

Irene Hoxie, Daniel C. Adelsberg, Iden A. Sapse, Robert Andreata‐Santos, Jeremy S. Yong +14 more

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase

Immunity(2024)10.1016/j.immuni.2024.01.017

N/A

0.749DataRank · unranked

146 citations

Juan Manuel Carreño, Charles Gleason, Brian Monahan, Gagandeep Singh, Anass Abbad +48 more

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

medRxiv(2021)10.1101/2021.09.17.21263758

N/A

0.486DataRank · unranked

8 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +41 more

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer

Cancer Cell(2022)10.1016/j.ccell.2022.04.012

N/A

0.442DataRank · unranked

18 citations

Jorge Gómez, Ananda M. Rodilla, Juan Manuel Carreño, Chih–Yuan Hsu, Christian Rolfo +43 more

Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.104486

N/A

0.416DataRank · unranked

15 citations

Sacha Gnjatic, Florian Krammer, Kevin Tuballes, Juan Manuel Carreño, Sammita Satyanarayan +16 more

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.28.582613

N/A

0.345DataRank · unranked

9 citations

Irene Hoxie, Daniel C. Adelsberg, Iden A. Sapse, Robert Andreata‐Santos, Jeremy S. Yong +14 more

SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101474

N/A

0.330DataRank · unranked

8 citations

Temima Yellin, Gagandeep Singh, M. Fried, Ariel Raskin, Johnstone Tcheou +23 more

Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

medRxiv(2022)10.1101/2022.02.01.22270253

N/A

0DataRank · unranked

3 citations

Vũ Đình Thiểm, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thị Ngọc Đặng +28 more

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

Nature Communications(2022)10.1038/s41467-022-32389-8

N/A

0DataRank · unranked

168 citations

Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason +25 more

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

medRxiv(2022)10.1101/2022.04.15.22273914

N/A

0DataRank · unranked

6 citations

Gagandeep Singh, Johnstone Tcheou, Komal Srivastava, Charles Gleason, Hiromi Muramatsu +8 more

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron

Nature(2021)10.1038/s41586-022-04399-5

N/A

0DataRank · unranked

533 citations

Hala Alshammary, Johnstone Tcheou, Gagandeep Singh, Ariel Raskin, Hisaaki Kawabata +38 more

SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023

medRxiv(2023)10.1101/2023.12.18.23300131

N/A

0DataRank · unranked

2 citations

Abram L. Wagner, Brian Monahan, Daniel Floda, Ana S. Gonzalez‐Reiche, Johnstone Tcheou +14 more

SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023

Nature Communications(2024)10.1038/s41467-024-50052-2

N/A

0DataRank · unranked

17 citations

Abram L. Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ana S. Gonzalez‐Reiche +27 more